Halozyme licenses drug delivery technology to Vertex for $15 million
Go back to Halozyme licenses drug delivery technology to Vertex for $15 million| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 113.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.90 | 52 Week High | $18.39 | |||
| Open | $113.90 | 52 Week Low | $6.96 | |||
| Day High | $113.90 | P/E | N/A | |||
| Day Low | $113.90 | EPS | $-0.58 | |||
| Volume | 324 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 526.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $526.19 | 52 Week High | $134.71 | |||
| Open | $526.19 | 52 Week Low | $73.31 | |||
| Day High | $526.19 | P/E | N/A | |||
| Day Low | $526.19 | EPS | $-1.98 | |||
| Volume | 560 | |||||
